Travere Therapeutics, Inc. (0001438533) (Filer) — SEC 8-K Filing
Travere Therapeutics
May 11, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Interim HealthCare Inc. has acquired its second-largest, long-tenured franchise in its network, transferring ownership of the operation from the franchisee to Interim corporate. The franchise serves the upstate and Midlands of South Carolina and includes a hospice location in Atlanta.
Financial terms were undisclosed. The acquired franchise employs close to 800 people, serves more than 3,000 patients daily, and conducts more than 350,000 patient visits annually, according to an Interim spokesperson. Interim plans to maintain ownership and has no plans to re-sell the franchise.
The franchise was previously owned by InvestSouth, which said care teams will continue delivering the same trusted service backed by Interim HealthCare’s clinical, operational, and support resources.
Filed under
Source
Read full article on news.google.comvia GN - urgent care home health hospice · January 16, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Travere Therapeutics
May 11, 2026
Pharvaris
May 11, 2026
Partner Therapeutics→Bizengri (bispecific antibody)
May 11, 2026
The Surgery Center of Southern Oregon
May 11, 2026
Mobia Medical
May 11, 2026